Jean-Yves Pavee, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 1,422 shares at $38.97 ($55K) on 2014-02-18, disclosed to the SEC on 2014-02-19.
Scheduled sale ($55k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.81 | 608 | $24K | 42.7% |
| 2 | $38.81 | 325 | $13K | 22.8% |
| 3 | $38.97 | 489 | $19K | 34.5% |
| Total | $38.87 avg | 1,422 | $55K | 100% |
| Filing → |
| ABT | SELL | 2015-06-05 | $515K | — | Filing → |
| ABT | SELL | 2015-03-03 | $31K | — | Filing → |
| ABT | SELL | 2015-02-18 | $29K | — | Filing → |